商標ウォッチ

TOP｜特許｜意匠｜商標

商標ウォッチ Twitter

公開日2024-11-13
公報種別公開国際商標公報
国際登録番号1808887
国際登録日2024-01-16
区分第1類(化学品),第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Chemical and biochemical preparations for scientific purposes, in particular in the form of protein, nucleic acid, or cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for laboratory and experimentation purposes, in particular for conducting experimental assays, other than for medical or veterinary purposes; reagents for scientific and research use, namely, reagents such as proteins and nucleic acids for modifying cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).,Pharmaceutical preparations, in particular in the form of protein 全 72 件を表示, nucleic acid, or cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections; living cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); biological preparations in the form of protein, nucleic acid, or cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections; therapeutic pharmaceuticals utilizing cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages in the treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections; cell preparations such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).,Scientific and technological services, namely, scientific research, analysis and testing in the field of biology, pharmaceuticals and cell therapy; biological research and development; medical, pharmaceutical and biotechnological research.,Medical services, in particular in the field of immunotherapy, in particular in the field of immuno-oncology; medical services in the field of hyperproliferative diseases; medical services in the field of cancer; medical services in the field of anti-infectives; in particular all of the aforesaid services related to the use of protein, nucleic acid, or cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).
基礎出願番号98088355
基礎出願日2023-07-17
基礎出願国US
出願人NKILT Therapeutics, Inc.
OCRテキストCIK
OCRテキスト2CIR
OCRについて

この商標をJ-PlatPatで参照する

関連商標

HYDROMECANIQUE ET FROTTEMENT

ME GROUP FRANCE

Setral Chemie GmbH

ROQUETTE FRERES

Sika Technology AG

HYDROMECANIQUE ET FROTTEMENT

POLYPLUS TRANSFECTION

Johnson Matthey Public Limited Company

BIONTE NUTRITION, S.L.

Krzysztof Jarosz

KINGSPAN HOLDINGS (IRL) LIMITED

CHAO WEALTH GROUP CO., LTD.

JIANGSU LOPAL TECH. CO.,LTD

SYNGENTA CROP PROTECTION AG

E-Lyte Innovations GmbH

HEALTHTECH BIO ACTIVES S.L.

JIANGSU LOPAL TECH. CO., LTD

PROBIOTICAL S.P.A.

JCWORKS CO., LTD.

LAMBERTI S.p.A.

Calgon Carbon Corporation

Tessenderlo Group NV

Ravensberger Schmierstoffvertrieb GmbH

JIANGSU LOPAL TECH CO., LTD.

続きを見る